Skip to content

Big Pharma’s New Model Of Orphan Drugs Verses The Traditional Blockbuster Drug Model: Editorial

December 31, 2012

       The Editor-In-Chief of a new international, peer-reviewed journal, Expert Opinion on Orphan Drugs, is Prof. M. Ian Phillips, Director of the Center for Rare Disease Therapies at the Keck Graduate Institute of Applied Life Sciences, in California. The first issue, the January 2013 (Vol. 1, No. 1) is available online.

Prof. Phillips writes an interesting Editorial for the inaugural January 2013 issue, on the popular topic of Big Pharma’s replacement of the traditional blockbuster drug model, with a new model for rare diseases and orphan drugs. The Editorial discusses :

1) The traditional blockbuster drug model

2)  The new emerging drug model for rare diseases and orphan drugs

3)  Answering the question of whether or not orphan drugs can be profitable for Big Pharma

4)  The future of rare diseases and orphan drugs for Big Pharma.

The citation for the Editorial :

Big Pharma’s new model in orphan drugs and rare diseases. M Ian Phillips. Expert Opinion on Orphan Drugs. Jan 2013; 1(1): 1-3.

       The topic of the new model of orphan drugs for Big Pharma and its profitability was the main Internet Buzz during the Summer of 2012, when Thomson Reuters came out with their article titled, “The New Blockbusters: Orphan Drugs”.

FierceBiotech.com’s August 22, 2012 article, discusses whether or not orphan drugs are profitable for Big Pharma :

– Growth rate for orphan drug revenue = 25.8%, over 10 years

– Orphan drug market now worth > $50 million

– Oncology is largest therapeutic area for new orphan drugs.

Check out the infographic in the FierceBiotech.com article provided by Thomson Reuters Cortellis.

References

Drug Discovery & Development article titled, “Orphan Drugs Economically Viable”

IP Solutions Blog article titled, “Orphan Drugs Show Blockbuster Potential”.

Copyright © 2012-2013, Orphan Druganaut Blog. All rights reserved.

Advertisements
Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: